Motif ID: Prdm1
Z-value: 1.251
Transcription factors associated with Prdm1:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Prdm1 | ENSMUSG00000038151.6 | Prdm1 |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 13.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
4.0 | 12.1 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
3.5 | 13.9 | GO:0006867 | asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
3.0 | 9.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
2.7 | 8.0 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
2.6 | 7.7 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
2.4 | 7.2 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
2.3 | 6.9 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
2.0 | 6.0 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
2.0 | 5.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.9 | 5.8 | GO:1990481 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) snRNA pseudouridine synthesis(GO:0031120) mRNA pseudouridine synthesis(GO:1990481) |
1.9 | 13.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.7 | 8.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.6 | 4.7 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
1.6 | 6.3 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
1.5 | 4.6 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
1.5 | 6.2 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
1.4 | 2.7 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
1.3 | 5.4 | GO:0035934 | corticosterone secretion(GO:0035934) |
1.2 | 13.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
1.1 | 11.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.0 | 4.1 | GO:1903416 | response to glycoside(GO:1903416) |
1.0 | 9.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.9 | 4.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.9 | 2.6 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.8 | 9.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.7 | 2.2 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.7 | 3.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.7 | 2.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.7 | 6.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.6 | 5.8 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.6 | 8.8 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.6 | 2.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.6 | 4.6 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.6 | 10.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.6 | 2.8 | GO:0003383 | apical constriction(GO:0003383) |
0.5 | 3.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.5 | 8.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.5 | 3.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.5 | 4.6 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.5 | 4.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) protein K6-linked ubiquitination(GO:0085020) |
0.5 | 16.2 | GO:0046677 | response to antibiotic(GO:0046677) |
0.5 | 1.8 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.4 | 1.7 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.4 | 1.6 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.4 | 1.2 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.3 | 2.6 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.3 | 17.3 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.3 | 7.6 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.3 | 3.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 2.1 | GO:0043383 | negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
0.3 | 2.0 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 0.7 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 1.2 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.2 | 1.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 11.6 | GO:0015914 | phospholipid transport(GO:0015914) |
0.2 | 2.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 1.6 | GO:0061009 | common bile duct development(GO:0061009) |
0.2 | 1.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 1.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.5 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.2 | 1.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 1.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 1.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.7 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 3.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 2.0 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.4 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) serotonin secretion by platelet(GO:0002554) |
0.1 | 5.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 5.1 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 5.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.5 | GO:0072592 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) oxygen metabolic process(GO:0072592) |
0.1 | 0.3 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.1 | 0.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 5.6 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.1 | 3.6 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.8 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.1 | 0.9 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.4 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 10.3 | GO:0048814 | regulation of dendrite morphogenesis(GO:0048814) |
0.1 | 0.3 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 3.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 2.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 1.2 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 1.7 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.3 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 0.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 2.6 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.5 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.3 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 3.0 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.0 | 1.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 1.0 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 1.1 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.0 | 5.8 | GO:0051099 | positive regulation of binding(GO:0051099) |
0.0 | 1.6 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.5 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 2.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 9.0 | GO:0043010 | camera-type eye development(GO:0043010) |
0.0 | 0.1 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.0 | 1.7 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
0.0 | 1.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.3 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 1.2 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.0 | 2.1 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 1.0 | GO:0009636 | response to toxic substance(GO:0009636) |
0.0 | 0.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 1.5 | GO:0060348 | bone development(GO:0060348) |
0.0 | 0.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 1.2 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.3 | GO:0031648 | protein destabilization(GO:0031648) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
2.0 | 6.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
2.0 | 5.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.7 | 6.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.5 | 5.8 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.0 | 7.9 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.9 | 14.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.8 | 3.2 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.6 | 4.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.5 | 4.6 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.5 | 4.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.5 | 2.7 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.4 | 1.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 3.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 2.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 16.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 2.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 8.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 1.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.2 | 8.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 2.7 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 12.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 4.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 9.1 | GO:0005844 | polysome(GO:0005844) |
0.1 | 3.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 2.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 9.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 2.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 1.5 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 2.1 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 0.5 | GO:0071438 | NADPH oxidase complex(GO:0043020) invadopodium membrane(GO:0071438) |
0.1 | 1.6 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 4.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 3.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 2.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 5.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.4 | GO:0034715 | U7 snRNP(GO:0005683) pICln-Sm protein complex(GO:0034715) |
0.1 | 0.7 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 8.7 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 11.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 2.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 1.0 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 5.5 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 5.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 1.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 11.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 9.2 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 17.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 2.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 1.2 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 2.0 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 2.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 4.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 2.6 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 1.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 4.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 3.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 1.2 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 20.5 | GO:1903561 | extracellular organelle(GO:0043230) extracellular vesicle(GO:1903561) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 13.7 | GO:0004454 | ketohexokinase activity(GO:0004454) |
4.0 | 16.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
2.8 | 13.9 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
2.3 | 9.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
2.3 | 13.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
2.1 | 6.2 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) dinucleotide insertion or deletion binding(GO:0032139) |
2.1 | 10.3 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
1.9 | 11.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.6 | 4.7 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
1.5 | 4.6 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
1.5 | 5.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.3 | 7.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
1.0 | 5.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.9 | 7.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.8 | 2.4 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.7 | 2.2 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.7 | 2.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.7 | 6.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.6 | 4.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.6 | 4.0 | GO:0045703 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.6 | 8.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.5 | 1.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.5 | 2.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.5 | 1.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.5 | 12.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.5 | 9.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 1.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.4 | 5.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 8.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.4 | 1.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 5.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 6.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 2.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 3.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.3 | 1.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 4.6 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.2 | 1.2 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.2 | 1.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 1.4 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 4.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 3.2 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 8.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 1.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 3.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 6.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 2.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.5 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 0.7 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 2.1 | GO:0015149 | glucose transmembrane transporter activity(GO:0005355) hexose transmembrane transporter activity(GO:0015149) |
0.1 | 2.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 7.9 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 8.7 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.4 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 3.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 12.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) U7 snRNA binding(GO:0071209) |
0.1 | 0.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 2.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 8.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 4.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.4 | GO:0033814 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.1 | 5.4 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 4.7 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.8 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 8.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 4.2 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 4.9 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 10.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 1.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 3.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.5 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.3 | GO:0015168 | structural constituent of eye lens(GO:0005212) glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.7 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 2.1 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 14.4 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 6.7 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 1.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 1.0 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.8 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 3.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 1.1 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.6 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.0 | 0.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.0 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.0 | 3.2 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 1.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |